Home/Filings/4/0001299130-21-000070
4//SEC Filing

ORDONEZ KATHY 4

Accession 0001299130-21-000070

CIK 0001299130other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:52 PM ET

Size

31.0 KB

Accession

0001299130-21-000070

Insider Transaction Report

Form 4
Period: 2021-02-16
Transactions
  • Exercise/Conversion

    Common Stock

    2021-02-16$6.98/sh+35,000$244,30091,767 total
  • Exercise/Conversion

    Common Stock

    2021-02-16$5.79/sh+25,000$144,750116,767 total
  • Exercise/Conversion

    Common Stock

    2021-02-16$8.98/sh+25,000$224,500141,767 total
  • Exercise/Conversion

    Common Stock

    2021-02-16$3.81/sh+25,000$95,250166,767 total
  • Exercise/Conversion

    Common Stock

    2021-02-16$2.90/sh+25,485$73,907192,252 total
  • Exercise/Conversion

    Common Stock

    2021-02-16$2.63/sh+50,394$132,536242,646 total
  • Sale

    Common Stock

    2021-02-16$47.58/sh118,667$5,646,651123,979 total
  • Sale

    Common Stock

    2021-02-16$48.47/sh101,004$4,895,26022,975 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1635,0000 total
    Exercise: $6.98Exp: 2024-12-17Common Stock (35,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1625,0000 total
    Exercise: $3.81Exp: 2027-05-24Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1650,39437,106 total
    Exercise: $2.63From: 2018-03-15Exp: 2028-03-15Common Stock (50,394 underlying)
  • Sale

    Common Stock

    2021-02-16$49.00/sh1,100$53,90021,875 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1625,0000 total
    Exercise: $5.79Exp: 2025-05-20Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1625,0000 total
    Exercise: $8.98Exp: 2026-05-17Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-02-1625,485324,515 total
    Exercise: $2.90From: 2017-12-15Exp: 2027-11-15Common Stock (25,485 underlying)
Footnotes (4)
  • [F1]This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
  • [F2]This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
  • [F3]The shares subject to the option are fully vested and exercisable
  • [F4]The shares subject to the option vest in equal monthly installment, over a four year period

Issuer

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

CIK 0001299130

Entity typeother

Related Parties

1
  • filerCIK 0001222643

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:52 PM ET
Size
31.0 KB